OpenPV Signal Explorer
FAERS disproportionality dashboard
Reaction

Sacroiliitis reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,872 reports · 58 co-occurring drugs

As of the last recalculation, Sacroiliitis appears in 1,872 FAERS reports alongside 58 co-occurring drug terms. The strongest observed disproportionality signal is QUININE (PRR 73.4).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Quinine5573.473.9
Adalimumab-Fkjp18549.249.4
Adalimumab-Aaty18347.547.7
Isotretinoin18846.947.0
Adalimumab-Adaz19245.045.1
Methylprednisolone Acetate2738.038.1
Naproxen17527.227.3
Sulfasalazine17327.027.0
Diclofenac18626.526.6
Amitriptyline Hydrochloride3824.624.6
Indomethacin2823.823.9
Tramadol Hydrochloride6319.219.3
Celecoxib20319.119.1
Tofacitinib Citrate2118.018.0
Diclofenac Sodium21017.417.4
Secukinumab21917.017.0
Diclofenac Potassium, Film Coated1216.016.0
Diclofenac Potassium Tablets1215.916.0
Infliximab-Dyyb4115.915.9
Naproxen Sodium18515.915.9
Cholestyramine1715.815.8
Diclofenac Potassium1313.513.5
Meloxicam6713.313.3
Methotrexate Sodium42112.112.1
Methotrexate37112.012.0
Desoximetasone2011.811.8
Ustekinumab10211.711.7
Golimumab8211.111.1
Bupivacaine910.810.8
Cyclobenzaprine4510.310.3
Adalimumab49610.210.3
Calcium Gluconate1110.210.2
Rosuvastatin Calcium2510.010.0
Diclofenac Sodium 1%319.89.8
Diclofenac Sodium Topical319.89.8
Diclofenac Sodium Topical Gel, 1%319.89.8
Azathioprine749.79.7
Infliximab1749.79.7
Chlorthalidone109.69.6
Rabeprazole Sodium229.19.1
Anakinra138.88.8
Cefazolin78.68.6
Certolizumab Pegol858.48.4
Duloxetine Hydrochloride1338.48.4
Leflunomide727.97.9
Vedolizumab567.47.4
Naproxen Sodium Tablet, Coated86.66.6
Naproxen Sodium, Coated Tablets86.66.6
Naproxen Sodium 220Mg86.66.6
Bimekizumab126.36.3
Etanercept2826.06.0
Acetaminophen And Codeine65.55.5
Botulinum Toxin Type A54.54.5
Upadacitinib314.34.3
Ixekizumab144.24.2
Emtricitabine And Tenofovir Alafenamide32.92.9
Apremilast332.52.5
Guselkumab72.22.2

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.